{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T14:21:49Z","timestamp":1770474109736,"version":"3.49.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1097\/jcp.0b013e3182979a0a","type":"journal-article","created":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T13:15:08Z","timestamp":1375190108000},"page":"682-685","source":"Crossref","is-referenced-by-count":22,"title":["Estimated Dopamine D2 Receptor Occupancy and Remission in Schizophrenia"],"prefix":"10.1097","volume":"33","author":[{"given":"Sho","family":"Moriguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert R.","family":"Bies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Remington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takefumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Mamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce G.","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210128","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition.","volume":"161","author":"Lehman","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R2-14-20210128","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/schbul\/sbp149","article-title":"Low dose vs standard dose of antipsychotics for relapse prevention in schizophrenia: meta-analysis.","volume":"37","author":"Uchida","year":"2011","journal-title":"Schizophr Bull"},{"key":"R3-14-20210128","doi-asserted-by":"crossref","first-page":"19S","DOI":"10.1097\/00004714-199502001-00004","article-title":"Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients.","volume":"15","author":"Farde","year":"1995","journal-title":"J Clin Psychopharmacol"},{"key":"R4-14-20210128","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1176\/appi.ajp.157.4.514","article-title":"Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.","volume":"157","author":"Kapur","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R5-14-20210128","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/JCP.0b013e3182214aad","article-title":"Dopamine d2 receptor occupancy and clinical effects: a systematic review and pooled analysis.","volume":"31","author":"Uchida","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"R6-14-20210128","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","article-title":"Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.","volume":"49","author":"Farde","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"R7-14-20210128","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/schbul\/sbr189","article-title":"Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data.","volume":"39","author":"Sakurai","year":"2013","journal-title":"Schizophr Bull"},{"key":"R8-14-20210128","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1176\/ajp.152.2.173","article-title":"D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate.","volume":"152","author":"Nyberg","year":"1995","journal-title":"Am J Psychiatry"},{"key":"R9-14-20210128","first-page":"80","article-title":"Treatment target in schizophrenia: a critical review and a clinical suggestion.","volume":"41","author":"Suzuki","year":"2008","journal-title":"Psychopharmacol Bull"},{"key":"R10-14-20210128","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.4088\/JCP.09m05866yel","article-title":"Extended antipsychotic dosing in the maintenance treatment of schizophrenia: a double-blind, placebo-controlled trial.","volume":"72","author":"Remington","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"R11-14-20210128","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/JCP.0b013e318218d339","article-title":"Predicting dopamine D receptor occupancy from plasma levels of antipsychotic drugs: a systematic review and pooled analysis.","volume":"31","author":"Uchida","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"R12-14-20210128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/clpt.2009.133","article-title":"Predicting age-specific dosing of antipsychotics.","volume":"86","author":"Uchida","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"R13-14-20210128","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.schbul.a006986","article-title":"The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development.","volume":"29","author":"Stroup","year":"2003","journal-title":"Schizophr Bull"},{"key":"R14-14-20210128","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2125.2008.03276.x","article-title":"Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study.","volume":"66","author":"Feng","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"R15-14-20210128","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1177\/0091270010387604","article-title":"Population pharmacokinetic modeling of ziprasidone in patients with schizophrenia from the CATIE study.","volume":"51","author":"Wessels","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"R16-14-20210128","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0091270007310385","article-title":"Sex, race, and smoking impact olanzapine exposure.","volume":"48","author":"Bigos","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"R17-14-20210128","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus.","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R18-14-20210128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia.","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"R19-14-20210128","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF01061728","article-title":"Estimation of population characteristics of pharmacokinetic parameters from routine clinical data.","volume":"5","author":"Sheiner","year":"1977","journal-title":"J Pharmacokinet Biopharm"},{"key":"R20-14-20210128","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1073\/pnas.89.15.7144","article-title":"At least five related, but distinct, hepatitis C viral genotypes exist.","volume":"89","author":"Cha","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-14-20210128","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/FTD.0b013e3182489a6f","article-title":"Predicting plasma concentration of risperidone associated with dosage change: a population pharmacokinetic study.","volume":"34","author":"Uchida","year":"2012","journal-title":"Ther Drug Monit"},{"key":"R22-14-20210128","first-page":"S65","article-title":"Predicting dopamine D2 receptor occupancy following antipsychotic dose reduction: a pilot PET study.","volume":"261","author":"Uchida","year":"2011","journal-title":"Eur Arch Clin Neurosci"},{"key":"R23-14-20210128","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.pnpbp.2011.12.013","article-title":"Dopamine D2 receptor occupancy with risperidone or olanzapine during maintenance treatment of schizophrenia: a cross-sectional study.","volume":"37","author":"Mizuno","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R24-14-20210128","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death.","volume":"360","author":"Ray","year":"2009","journal-title":"N Engl J Med"},{"key":"R25-14-20210128","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.biopsych.2004.10.023","article-title":"Continuous but not intermittent olanzapine infusion induces vacuous chewing movements in rats.","volume":"57","author":"Turrone","year":"2005","journal-title":"Biol Psychiatry"},{"key":"R26-14-20210128","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/npp.2011.10","article-title":"Continuous, but not intermittent, antipsychotic drug delivery intensifies the pursuit of reward cues.","volume":"36","author":"Bedard","year":"2011","journal-title":"Neuropsychopharmacology"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e3182979a0a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T17:48:33Z","timestamp":1715795313000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201310000-00014"}},"subtitle":["Analysis of the CATIE Data"],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3182979a0a","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}